Press Release
Category Added in a WPeMatico Campaign
-
Business Wire22 May 2026
DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor candidates
AstraZeneca and Daiichi Sankyo’s DATROWAY is the only TROP2-directed antibody drug conjugate to prolong overall survival in this setting vs.…
Read More » -
Business Wire22 May 2026
DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor candidates
AstraZeneca and Daiichi Sankyo’s DATROWAY is the only TROP2-directed antibody drug conjugate to prolong overall survival in this setting vs.…
Read More » -
Business Wire22 May 2026
DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor candidates
AstraZeneca and Daiichi Sankyo’s DATROWAY is the only TROP2-directed antibody drug conjugate to prolong overall survival in this setting vs.…
Read More » -
Business Wire22 May 2026
PharmaEssentia to Present New Clinical Data Supporting the Use of Ropeginterferon Alfa-2b in Essential Thrombocythemia at ASCO and EHA 2026
Two-year and post-hoc SURPASS-ET analyses highlight the impact of treatment timing, with durable responses and improved progression-free survival supporting consideration…
Read More » -
Business Wire22 May 2026
ISG to Study UKG Pro Ecosystem Service Providers
Upcoming ISG Provider Lens® report will evaluate providers that modernize workforce operations with AI, data integration and continuous optimization STAMFORD,…
Read More » -
Business Wire22 May 2026
ISG to Study UKG Pro Ecosystem Service Providers
Upcoming ISG Provider Lens® report will evaluate providers that modernize workforce operations with AI, data integration and continuous optimization STAMFORD,…
Read More » -
Business Wire22 May 2026
ISG to Study UKG Pro Ecosystem Service Providers
Upcoming ISG Provider Lens® report will evaluate providers that modernize workforce operations with AI, data integration and continuous optimization STAMFORD,…
Read More » -
Business Wire22 May 2026
ZFLOW AI’s Simulation-Guided Optimization Identifies a 1.54× Higher-Throughput Serving Configuration for DeepSeek V4-Pro on 8×B300
Working on PaleBlueDot AI’s NVIDIA B300 platform, ZFLOW AI used hardware-aware simulation to find an optimized SGLang serving configuration for…
Read More » -
Business Wire22 May 2026
Datroway® Approved in the U.S. as First TROP2 Directed Antibody Drug Conjugate for First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
Daiichi Sankyo and AstraZeneca’s Datroway is the only TROP2 directed antibody drug conjugate to prolong overall survival in this setting…
Read More » -
Business Wire22 May 2026
COTY FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Coty (COTY) Investors of Securities Class Action Deadline on May 22, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Coty To Contact Him…
Read More »